Answer
Treatment should normally be postponed until after childbirth because pregnancy safety data are limited. Exceptional use needs specialist assessment.
Sources for this answer
- Fibrovein 3%, 1%, 0.5%, 0.2% — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.